DE69830660D1 - Behandlung von atemstillstand im schlaf - Google Patents

Behandlung von atemstillstand im schlaf

Info

Publication number
DE69830660D1
DE69830660D1 DE69830660T DE69830660T DE69830660D1 DE 69830660 D1 DE69830660 D1 DE 69830660D1 DE 69830660 T DE69830660 T DE 69830660T DE 69830660 T DE69830660 T DE 69830660T DE 69830660 D1 DE69830660 D1 DE 69830660D1
Authority
DE
Germany
Prior art keywords
breathing
sleep
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69830660T
Other languages
English (en)
Other versions
DE69830660T2 (de
Inventor
C Meyer
Safwan Badr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of DE69830660D1 publication Critical patent/DE69830660D1/de
Application granted granted Critical
Publication of DE69830660T2 publication Critical patent/DE69830660T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69830660T 1997-04-16 1998-04-16 Behandlung von atemstillstand im schlaf Expired - Fee Related DE69830660T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US834369 1997-04-16
US08/834,369 US5958902A (en) 1997-04-16 1997-04-16 Method and composition for treating sleep apnea
PCT/US1998/007735 WO1998046245A1 (en) 1997-04-16 1998-04-16 Method and composition for treating sleep apnea

Publications (2)

Publication Number Publication Date
DE69830660D1 true DE69830660D1 (de) 2005-07-28
DE69830660T2 DE69830660T2 (de) 2006-05-04

Family

ID=25266775

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69830660T Expired - Fee Related DE69830660T2 (de) 1997-04-16 1998-04-16 Behandlung von atemstillstand im schlaf

Country Status (24)

Country Link
US (3) US5958902A (de)
EP (1) EP1009411B1 (de)
JP (1) JP2001507364A (de)
KR (1) KR100381643B1 (de)
CN (1) CN1252727A (de)
AR (1) AR012221A1 (de)
AT (1) ATE298241T1 (de)
AU (1) AU722866B2 (de)
BG (1) BG103800A (de)
BR (1) BR9809090A (de)
CA (1) CA2285574C (de)
CO (1) CO4940399A1 (de)
DE (1) DE69830660T2 (de)
HK (1) HK1026141A1 (de)
HU (1) HUP0002645A3 (de)
ID (1) ID29298A (de)
IL (2) IL132133A0 (de)
NO (1) NO994613L (de)
NZ (1) NZ337969A (de)
PL (1) PL336326A1 (de)
SK (1) SK143199A3 (de)
TR (1) TR199902577T2 (de)
TW (1) TWI221771B (de)
WO (1) WO1998046245A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6641542B2 (en) * 2001-04-30 2003-11-04 Medtronic, Inc. Method and apparatus to detect and treat sleep respiratory events
WO2003070178A2 (en) * 2002-02-15 2003-08-28 Cns, Inc. Throat spray
ES2609482T3 (es) 2002-03-20 2017-04-20 Civitas Therapeutics, Inc. Administración pulmonar de levodopa
US7992566B2 (en) 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US7647931B2 (en) 2002-12-30 2010-01-19 Quiescence Medical, Inc. Stent for maintaining patency of a body region
WO2007005672A2 (en) * 2005-06-30 2007-01-11 The Scripps Research Institute Treatment and prevention of respiratory diseases and conditions
JP2007190277A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器および呼吸訓練プログラム
JP2007190275A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器
JP2007190278A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器
WO2007098200A2 (en) 2006-02-16 2007-08-30 Imthera Medical, Inc. An rfid-based apparatus, system, and method for therapeutic treatment of obstructive sleep apnea
US7734350B2 (en) * 2006-06-14 2010-06-08 Zmed Technologies, Inc. Respiration apparatus
WO2007147046A2 (en) * 2006-06-14 2007-12-21 Zmed Technologies, Inc. Respiration stimulation
WO2008006090A2 (en) 2006-07-06 2008-01-10 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US20100198103A1 (en) 2007-10-09 2010-08-05 Imthera Medical, Inc. System and method for neural stimulation
EP2534958A1 (de) 2007-12-14 2012-12-19 AeroDesigns, Inc Abgabe von Aerosol-sprühbaren Nahrungsmittelprodukten
CA2738479C (en) 2008-10-09 2017-11-28 Imthera Medical, Inc. Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue
JP2013509943A (ja) 2009-11-10 2013-03-21 イムセラ・メディカル・インコーポレーテッド 舌下神経を刺激して患者の舌の位置を調節するシステム
EP2608717B1 (de) 2010-08-26 2016-05-11 Ben Gurion University of The Negev Research and Development Authority Vorrichtung zur diagnose von obstruktiver schlafapnoe
WO2012082791A2 (en) 2010-12-13 2012-06-21 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US20120220531A1 (en) 2011-02-04 2012-08-30 Cincinnati Children's Hospital Medical Center Surfactant protein d for the treatment of disorders associated with lung injury
US10265014B2 (en) 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
US10265013B2 (en) 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
CN104982527A (zh) * 2015-07-30 2015-10-21 安徽人人福豆业有限公司 一种安神豆渣发酵乳及其制备方法
CN105123927A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种芦荟健胃豆渣发酵乳及其制备方法
CN105123926A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种疏肝理气豆渣发酵乳及其制备方法
CN105123928A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种润肠豆渣发酵乳及其制备方法
CN105010535A (zh) * 2015-07-30 2015-11-04 安徽人人福豆业有限公司 一种银耳豆渣发酵乳及其制备方法
CN105053195A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种去火薄荷味豆渣发酵乳及其制备方法
CN105053194A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种清热通络豆渣发酵乳及其制备方法
CN104996566A (zh) * 2015-07-30 2015-10-28 安徽人人福豆业有限公司 一种清肺酒香豆渣发酵乳及其制备方法
CN105053197A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种温中补血豆渣发酵乳及其制备方法
CN105053192A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种椰香补肾豆渣发酵乳及其制备方法
CN105104535A (zh) * 2015-07-30 2015-12-02 安徽人人福豆业有限公司 一种养颜豆渣发酵乳及其制备方法
CN105053191A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种消食木瓜豆渣发酵乳及其制备方法
CN105053196A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种风味草莓豆渣发酵乳及其制备方法
US10786449B2 (en) 2017-07-17 2020-09-29 Northriver Pharm, LLC Nasal composition comprising a mucoadhesive polymer
CN111568853B (zh) * 2020-04-30 2023-07-28 杭州濡湜生物科技有限公司 一种新型肺部智能释药系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2520234A1 (fr) * 1982-01-28 1983-07-29 Gros Pierre Composition destinee a la prevention du ronflement
US4826821A (en) * 1985-06-26 1989-05-02 The Regents Of The University Of California Lung surfactant compositions
JPS63503222A (ja) * 1986-05-06 1988-11-24 サイオス　ノバ　インコーポレイテッド 肺の疎水性界面活性物質に結合した分子量６，０００ダルトンのタンパク質及びその多量体
JPS63208524A (ja) * 1987-02-25 1988-08-30 Nippon Oil & Fats Co Ltd 睡眠リズム改善剤
US5238920A (en) * 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
DE69125750D1 (de) * 1990-05-21 1997-05-28 Abbott Lab Fettsäure-Oberflächenaktives-Lungenprotein Konjate
WO1993021221A1 (en) * 1992-04-10 1993-10-28 Abbott Laboratories Pulmonary surfactant protein fragments
US5569679A (en) * 1994-12-30 1996-10-29 Russell A. Krueger Pharmaceuticals, Inc. Pharmacologic management of snoring
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US5925334A (en) * 1997-08-27 1999-07-20 Rubin; Bruce K. Use of surface active agents to promote mucus clearance

Also Published As

Publication number Publication date
JP2001507364A (ja) 2001-06-05
IL132133A (en) 2008-12-29
EP1009411B1 (de) 2005-06-22
AR012221A1 (es) 2000-09-27
HUP0002645A2 (hu) 2001-06-28
CO4940399A1 (es) 2000-07-24
NZ337969A (en) 2001-12-21
TR199902577T2 (xx) 2000-02-21
ID29298A (id) 2001-08-16
NO994613L (no) 1999-10-28
CA2285574A1 (en) 1998-10-22
EP1009411A4 (de) 2002-10-09
KR20010006384A (ko) 2001-01-26
CA2285574C (en) 2007-11-13
HK1026141A1 (en) 2000-12-08
SK143199A3 (en) 2001-01-18
TWI221771B (en) 2004-10-11
CN1252727A (zh) 2000-05-10
AU6975598A (en) 1998-11-11
US20020099033A1 (en) 2002-07-25
NO994613D0 (no) 1999-09-23
EP1009411A1 (de) 2000-06-21
BR9809090A (pt) 2002-12-03
HUP0002645A3 (en) 2002-12-28
AU722866B2 (en) 2000-08-10
ATE298241T1 (de) 2005-07-15
BG103800A (en) 2000-03-31
DE69830660T2 (de) 2006-05-04
PL336326A1 (en) 2000-06-19
KR100381643B1 (ko) 2003-04-26
US6329352B1 (en) 2001-12-11
US5958902A (en) 1999-09-28
WO1998046245A1 (en) 1998-10-22
IL132133A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
DE69830660D1 (de) Behandlung von atemstillstand im schlaf
DE69726245D1 (de) Befeuchtungsgerät zur Behandlung von Atemstillstand im Schlaf
DE69916686D1 (de) Gerät zur Behandlung von Atemstillstand im Schlaf
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
ATE349428T1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
ID17156A (id) Zat-zat anti koagulan yang berguna dalam pengobatan trombosis
DE69817446D1 (de) Behandlung von diabetes
ATE229502T1 (de) Arylsulfonamide und analoga und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
DE69926385D1 (de) Behandlung von geweben
DE69500089D1 (de) Behandlung von Geflügel
DE69838338D1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
DE69835011D1 (de) Unterschiedliche behandlung von prothesenteilen
DE69823459D1 (de) Herzbehandlungssystem zur Feststellung und Behandlung von Herzversagen
DE69941566D1 (de) N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
DE59500555D1 (de) Mittel zur Wasserbehandlung
DE69524138D1 (de) Hautbehandlungsmittel
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
DE69912609D1 (de) Behandlung von in der luft enthaltenen mikroorganismen
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
ATE292975T1 (de) Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii
DE60017133D1 (de) Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose
DE69841550D1 (de) Behandlung von fibromyalgie und verwandten erkrankungen
ATE323685T1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69810499T2 (de) Behandlung von industriegeweben
ID24060A (id) Pengolahan kulit hewan yang ditingkatkan

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee